Article

Bilateral Temporal Glioma Presenting as a Paraneoplastic Limbic Encephalitis With Pure Cognitive Impairment

Department of Neurology and Memory Clinic, University Hospital of Lille and Lille II University, France.
The Neurologist (Impact Factor: 1.08). 08/2009; 15(4):208-11. DOI: 10.1097/NRL.0b013e31818fc022
Source: PubMed

ABSTRACT Memory impairment caused by bilateral hippocampal primitive brain tumor is rarely reported. Clinical and MRI features can mimic paraneoplastic limbic encephalitis (PLE), and the differential diagnosis between these 2 entities may be difficult.
We report the case of a 42-year-old woman presenting with amnesia without neurologic focal signs at clinical examination. The neuroimaging features consisted of bilateral limbic hyperintensities on T2-weighted and FLAIR brain MRI. Despite exhaustive biologic and radiologic investigations, no specific etiology was found. The diagnosis of paraneoplastic limbic encephalitis was suspected, although antineuronal antibodies were negative and no cancer was detected after the first evaluation. Eight months after onset, the memory complaint of the patient increased along with disability in activities of the daily living, the neurologic examination slightly changed with frontal neurologic signs and the brain MRI showed a new cystic lesion in the left hippocampus with enhancement after contrast administration. The left temporal tumor was resected and the neuropathological examination was consistent with gliomatosis cerebri with a focal high grade astrocytoma.
This case highlights the need to consider the possibility of infiltrative gliomatosis in patients presenting with features of paraneoplastic limbic encephalitis.

Download full-text

Full-text

Available from: Vincent Deramecourt, Jul 04, 2015
0 Followers
 · 
176 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Les démences représentent un problème de santé public majeur, notamment du fait du vieillissement des populations occidentales. Pourtant, le diagnostic étiologique de certitude d'un syndrome démentiel ne peut être obtenu que par l'analyse neuropathologique et/ou biochimique du tissu cérébral obtenu en post mortem. Les lésions cérébrales aboutissant au déclin cognitif ont des origines diverses (neurodégénératives, vasculaires, métaboliques...) et sont souvent associées. En analysant les données cliniques, neuropathologiques et biochimique issues de la cohorte autopsiques de patients déments suivis au Centre Mémoire de Ressources et de recherche du CHRU de Lille (127 cerveaux prélevés entre 1992 et 2009), nous avons étudié les corrélations entre l'expression clinique du syndrome démentiel et la nature des lésions cérébrales sous jacentes. Nous montrons que les fréquentes associations lésionnelles (lésions de maladie d'Alzheimer, de maladie à corps de Lewy, lésions vasculaires) ont des conséquences sur la pertinence du diagnostic étiologique du syndrome démentiel. Dans le domaine des dégénérescences lobaires frontotemporales (DLFT), nous avons étudié les corrélations clinicopathologiques de 18 patients ayant présenté des troubles inauguraux du langage ou de la parole. Nous avons pu établir des corrélations entre les syndromes cliniques et certaines protéinopathies (tau, TDP-43) associées aux DLFT. L'enquête génétique a permis de mettre en évidence une nouvelle mutation du gène de la progranuline chez un patient. L'analyse pluridisciplinaire des démences permet au clinicien de progresser dans la prédiction des lésions cérébrales du vivant du patient. Cette démarche s'avère indispensable dans l'optique du développement de traitements curatifs des démences neurodégénératives.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Paraneoplastic neurological syndromes (PNSs) cover a wide range of diseases and involve both the central nervous system (CNS) and peripheral nervous system. Paraneoplastic encephalitis comprises several diseases such as paraneoplastic cerebellar degeneration (PCD), limbic encephalitis (LE), paraneoplastic encephalomyelitis (PEM), brainstem encephalitis, opsomyoclonus syndrome, in addition to other even less frequently occurring entities. LE was the first historically identified CNS PNS, and similarities between other temporal lobe diseases such as herpes encephalitis have been elucidated. In the past few decades several autoantibodies have been described in association with LE. These encompass the classical 'onconeuronal' antibodies (abs) such as Hu, Yo, Ri and others, and now additionally abs towards either ion channels or surface antigens. The clinical core findings in LE are various mental changes such as amnesia or confusion, often associated with seizures. Careful characterization of psychiatric manifestations and/or associated neurological signs can help to characterize the syndrome and type of ab. The treatment options in LE depend on the aetiology. In LE caused by onconeuronal abs, the treatment options are poor. In two types of abs associated with LE, abs against ion channels and surface antigens (e.g. NMDA), immunomodulatory treatments seem effective, making these types of LE treatable conditions. However, LE can also occur without being associated with cancer, in which case only immunomodulation is required. Despite effective treatments, some patients' residual deficits remain, and recurrences have also been described.
    Therapeutic Advances in Neurological Disorders 07/2011; 4(4):237-48. DOI:10.1177/1756285611405395
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gliomatosis cerebri is a specific entity defined as a diffuse neoplastic glial cell infiltration of the brain, preserving the architecture of the normal surrounding tissues, involving more than 2 cerebral lobes. Clinical symptoms or radiologic features are nonspecific, and patients are often misdiagnosed with other neurologic diseases. Here, we report the diagnostic workup of 2 patients with gliomatosis cerebri, discussing the clinical, radiologic, and pathologic findings. Case 1: a 64-year-old woman who presented with an intracranial hypertension syndrome and had symmetrical white matter T2-weighted and fluid-attenuated inversion recovery hyperintensities pattern on magnetic resonance imaging; and case 2: a 54-year-old man with the diagnosis of multiple sclerosis for 8 years who presented with de novo cognitive impairment and focal deficits. This report highlights the difficulty of this differential diagnosis and the need of considering it also in the presence of a symmetrical pattern of white matter involvement. Cerebral biopsy remains crucial for the correct diagnosis and treatment approach.
    The Neurologist 09/2011; 17(5):269-72. DOI:10.1097/NRL.0b013e318217363e · 1.08 Impact Factor